MSD

    OverviewSuggest Edit

    MSD is a pharmaceutical company that develops medicines for humans and animals. It offers treatment such as heart and vascular disease, oncology, birth control, diabetes, anesthesia, vaccines, and more. The company also provides solutions for healthcare.
    TypePrivate
    Founded1923
    HQKenilworth, NJ, US
    Websitemsd.nl

    Latest Updates

    Employees (est.) (Jan 2022)1,496
    Cybersecurity ratingAMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    MSD Office Locations

    MSD has offices in Kenilworth, Algiers, Munro, Macquarie Park and in 64 other locations
    Kenilworth, NJ, US (HQ)
    2000 Galloping Hill Rd
    Munro, AR
    piso 4, EAA, Cazadores de Coquimbo 2841
    Macquarie Park, AU
    Building A - Level 1/26 Talavera Rd
    Wien, AT
    Ares Tower, Donau-City-Straße 11
    Baku, AZ
    90A Nizami St
    Manama, BH
    Salmaniya Avenue-2/Salmaniya
    Show all (84)

    MSD Financials and Metrics

    Summary Metrics

    Founding Date

    1923

    MSD Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    97/100

    SecurityScorecard logo

    MSD Online and Social Media Presence

    Embed Graph

    MSD News and Updates

    SOTIO Announces Clinical Collaboration with MSD to Evaluate IL-15 Superagonist, SOT101, in Combination with KEYTRUDA® (pembrolizumab) in Patients with Solid Tumors

    PRAGUE, Czech Republic, Dec. 08, 2021 (GLOBE NEWSWIRE) -- SOTIO Biotech, a clinical stage immuno-oncology company owned by PPF Group, announced today that it has entered into a clinical trial collaboration and supply agreement with MSD, a tradename of Merck & Co., Inc., Kenilworth, NJ., throug…

    MSD Partners appoints two as managing director

    MSD Partners has named Carlos Soto as a managing director and head of its business development of its private capital group.

    MSD Partners Expands Business Development and Investor Relations Teams of Its Private Capital Group with Key Appointments

    NEW YORK, Nov. 22, 2021 /PRNewswire/ -- MSD Partners, L.P. today announced that it has named Carlos Soto as a Managing Director and head of business development of its Private Capital Group (PCG). It also has named Federico Schiffrin as a Managing Director in its Strategic Partners Group,...

    MSD joins hands with Emirates Oncology Society and Friends of Cancer Patients for EMBRACE campaign to support Breast Cancer Awareness

    DUBAI, UAE, Oct. 24, 2021 /PRNewswire/ -- MSD, a leading global biopharmaceutical company, together with Emirates Oncology Society and Friends of Cancer Patients (FOCP), has announced the launch of EMBRACE, a campaign to mark Breast Cancer Awareness Month this October. The partners will...

    MSD Capital Buys 50% Of Digital Consultancy West Monroe

    MSD Capital Buys 50% Of Digital Consultancy West Monroe

    MSD Partners Announces Victor Hwang to Join as Co-Head of MSD Growth, the Firm's New Growth Investment Group

    NEW YORK, Oct. 14, 2021 /PRNewswire/ -- MSD Partners, L.P. today announced that it has named Victor Hwang Managing Director and Co-Head of the investment firm's newly formed Growth investment business. Mr. Hwang joins Dan Bitar, a Managing Director who is an 18-year veteran of MSD, in...
    Show more

    MSD Frequently Asked Questions

    • When was MSD founded?

      MSD was founded in 1923.

    • How many employees does MSD have?

      MSD has 1,496 employees.

    • Who are MSD competitors?

      Competitors of MSD include Seikagaku, Starodub and 7i Group.

    • Where is MSD headquarters?

      MSD headquarters is located at 2000 Galloping Hill Rd, Kenilworth.

    • Where are MSD offices?

      MSD has offices in Kenilworth, Algiers, Munro, Macquarie Park and in 64 other locations.

    • How many offices does MSD have?

      MSD has 84 offices.